| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |